Highlights
- 1Cancer discovery · 2022
- 2Scientific reports · 2021
- 3Cancers · 2020
Publications
Funding
Active
7 grants- PIU54HG013595-02The MSM Institute of Translational Genomic Medicine’s Center for Genomic ResearchNHGRI · 2024–2030 · via NIH RePORTER
- Co-ISAC160072Triple Negative Breast Cancer in Women with African AncestrySusan G. Komen Breast Cancer Foundation, Inc. · 2019–2028
- Co-IUL1TR002384-06Clinical and Translational Science Center - UL1National Center for Advancing Translational Sciences · 2022–2027
- Co-IW81XWH-19-1-0141Converting HR+ Breast Cancer Into an Individualized VaccineU.S. Department of Defense · 2019–2026
- Co-IW81XWH-21-2-0034Therapeutic targeting of breast cancer and host immune responses at inflection points in the disease trajectoryU.S. Department of Defense · 2021–2026
- Co-IW81XWH-21-1-0762Novel Complex Structural Variants And Epigenetic Alterations Link The Genomes Of Prostate Cancer In African Americans With Outcome Disparity.U.S. Department of Defense · 2021–2026
- PIOT2CA297574-01CANCER GRAND CHALLENGES 2024 SOCIETAL, ANCESTRY, MOLECULAR AND BIOLOGICAL ANALYSES OF INEQUALITIES (SAMBAI) Morehouse School of MedicineNCI · 2024–2026 · via NIH RePORTER
Completed grants (8)
- Co-INYGC 204878-03Unraveling the landscape of homologous recombination deficiency in patients with breast and prostate cancer across the African diaspora in NYCNew York Genome Center Inc. · 2020–2024
- PIBCRF 224993-01Geo-Spatial to Tumor-Spatial Influences of Ancestry and Race in Breast Cancer DisparitiesBreast Cancer Research Foundation · 2022–2023
- MPIR01CA259396-02The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune ResponseNational Cancer Institute · 2021–2023
- PIR13CA261076-015th Annual International Symposium: Improving Breast Cancer Management and OutcomesNational Cancer Institute · 2021–2023
- Co-IRG-1908-34822Defining ancestry associated B-cell inflammation in treatment naïve Multiple SclerosisNational Multiple Sclerosis Society · 2020–2022
- Co-IR21AI144819-01A1Determining Enhanced Inflammatory B cell Function in African Americans with MSNational Institute of Allergy and Infectious Diseases · 2020–2022
- PIF32GM074364-02Genome-wide Detection of Cell-specific Ecdysone TargetsNIGMS · 2005–2007 · via NIH RePORTER
Clinical research
Completed & closed trials (1)
- PIProspective analysis of the Duffy Antigen Receptor for Chemokines/Atypical Chemokine Receptor 1 (DARC/ACK1) and risk of triple negative breast cancer (TNBC)Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2024)
Available technologies
- DARC Diagnostic Test for Tumor Immunotherapy8495Application filedPMID 30944146
News mentions
- Biological Links Identified Between an Aggressive Breast Cancer Type and African AncestrySeptember 19, 2022
Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer.
- Department of Defense Awards Weill Cornell Medicine New Grant for Breast Cancer ResearchDecember 9, 2021
Weill Cornell Medicine has been awarded a nearly $6.5 million, four-year grant from the Department of Defense as part of a multi-institutional Transformative Breast Cancer Consortium.
- Breast Cancer Risk in African Americans Tied to Genetic VariationsJune 9, 2021
Two gene variants found in African American women may explain why they are more likely to be diagnosed with triple negative breast cancer (TNBC) than white women of European ancestry, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
- COVID-19 Research Grants Support Weill Cornell Medicine InvestigatorsSeptember 11, 2020
Weill Cornell Medicine has awarded eight grants of $100,000 each to faculty for a variety of research projects on COVID-19, funded by the institution’s Board of Overseers and additional donors. The grants will support studies aimed at understanding fundamental aspects of the disease, the body’s immune response and social determinants of health that affect COVID-19 outcomes.
- Closing the Gap: Working to Combat Racial Disparities in Breast Cancer OutcomesSeptember 6, 2019
Weill Cornell Medicine researchers are working to combat the stark racial disparities in breast cancer outcomes
Show 1 more mention
- Gene Variant May Explain Poor Breast Cancer Outcomes in Black WomenApril 3, 2019
A set of gene variants that originated in Sub-Saharan West African populations may help explain why black women, compared to white women, have worse breast cancer outcomes, according to a new study from a team led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
External relationships
Ownership
Genentech Inc
Advisory/Scientific Board Member
Genentech Inc
Other
Tuskegee University